Our results are consistent with human studies that have found increased survivin serum concentrations in humans with various malignant tumors, e.g., nasopharyngeal tumors (12, 13), and have described increased survivin expression in the mucosa of humans with chronic rhinosinusitis (CRS) (17). This evidence concerns the gene BIRC5 and chronic rhinosinusitis.